2023年4月24日

2018年Shelbourne酒店。形象:湯姆弗萊明(2.0 CC通過數控)所選的初創企業將有機會與國際專家、顧問和投資者來說,今年的隊列具有多個三一和RCSI剝離。一群34有前途的創業是互相對比最高獎項和一個潛在的現貨在今年的醫學技術創新者加速器。醫學技術創新者,總部位於加州,是世界上最知名的比賽和加速器在醫學技術初創企業創造新的技術,數字醫療和診斷空間。事件發生年度投手今天(4月24日)在都柏林的Shelbourne酒店,從池中參與創業選擇的1000多名國際應用程序。成功應聘者12愛爾蘭公司。今天的活動是被關押在夥伴關係與都柏林三一學院和皇家外科學院在愛爾蘭(RCSI)。這是兩個組織的知識轉移聯盟,旨在提高專業知識的共享,流程和程序。五個初創企業將選擇在明天跟進事件,之後評委和會議觀眾會選擇一個贏家。事件也將作為墊腳石的一些公司加入著名的醫學技術創新者2023計劃。 A total of $800,000 will be awarded this year, which includes a new $300,000 prize for mid-stage companies. Trinity start-up development manager Neil Gordon said the event is a “unique opportunity” for the 12 Irish companies to meet and engage with “Irish and international experts, mentors and investors”. Two of the Irish companies are Trinity spinouts. MitrAdapt is developing a repair device for mitral regurgitation, which is a type of heart valve disease where certain valves don’t close properly. Plio Surgical, meanwhile, is developing a minimally invasive implant for colorectal surgeries that heal fast and avoid any post-surgical complications such as leakage. Last year, Plio Surgical was one of many companies watching the 2022 MedTech Innovator pitching event, in preparation for pitching their own emerging tech ideas.